Cerebrovascular Disease News and Research RSS Feed - Cerebrovascular Disease News and Research

Cerebrovascular disease is a group of brain dysfunctions related to disease of the blood vessels supplying the brain. Hypertension is the most important cause; it damages the blood vessel lining, endothelium, exposing the underlying collagen where platelets aggregate to initiate a repairing process which is not always complete and perfect. Sustained hypertension permanently changes the architecture of the blood vessels making them narrow, stiff, deformed, uneven and more vulnerable to fluctuations in blood pressure.
UCSF study focuses on vexing problems of handling skin cancers among elderly patients

UCSF study focuses on vexing problems of handling skin cancers among elderly patients

Surgery is often recommended for skin cancers, but older, sicker patients can endure complications as a result and may not live long enough to benefit from the treatment. [More]

Cardiovascular disease grave in patients with bipolar disorder

Cardiovascular disease has a particularly large impact on life expectancy if patients also have bipolar disorder, say researchers. [More]
Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology, March 16-23, 2013, in San Diego. [More]
Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia. [More]

Stroke specialists offer guidance on questions about thrombolytic therapy use

One of the most challenging issues in stroke care involves the use of clot-busting drugs such as tPA. When given quickly enough and to the right patient, such drugs can minimize stroke damage by dissolving blood clots that cause most strokes. But these blood-thinning drugs also increase the risk of brain hemorrhages and other complications. [More]
Positive data from POZEN's PA32540 Phase 3 studies presented at AHA 2013 stroke conference

Positive data from POZEN's PA32540 Phase 3 studies presented at AHA 2013 stroke conference

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from the combined results of two Phase 3 studies of PA32540, an antiplatelet therapy of enteric-coated (EC) and immediate-release omeprazole, in patients with previous cerebrovascular disease. [More]
Calcium supplements may increase men’s death risk

Calcium supplements may increase men’s death risk

Men who have a high intake of supplemental calcium may be at an increased risk for cardiovascular disease death, report researchers. [More]
Antibiotic use common at the end of life

Antibiotic use common at the end of life

More than one-quarter of hospice patients receive antibiotics in their last week of life, despite the absence of documented infection in most cases, US researchers report. [More]
The Joint Commission, AHA/ASA recognize HUP with Comprehensive Stroke Center Certification

The Joint Commission, AHA/ASA recognize HUP with Comprehensive Stroke Center Certification

The Hospital of the University of Pennsylvania (HUP) has been recognized by The Joint Commission and the American Heart Association/American Stroke Association (AHA/ASA) as meeting The Joint Commission's standards for Disease-Specific Care Comprehensive Stroke Center Certification, becoming the first center in Philadelphia and among a select few hospitals in the United States to be named as part of an elite group of providers focused on complex stroke care. [More]
UC San Diego Health System receives Comprehensive Stroke Center designation

UC San Diego Health System receives Comprehensive Stroke Center designation

UC San Diego Medical Center-Hillcrest is one of five facilities in the country, and the only center in San Diego County, to be recognized as one of the first Comprehensive Stroke Centers (CSC), the newest level of certification for advanced stroke care awarded by The Joint Commission. [More]

Researchers find association between neuroscience providers and stroke-related deaths in US

Researchers at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, have found an association in the United States between a higher density of neurologists and neurosurgeons and a decreased risk of death from stroke. [More]

CHOP presents new findings on pediatric cardiovascular disease at AHA 2012

Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2012 in Los Angeles. [More]
Oily fish consumption may reduce risk of stroke

Oily fish consumption may reduce risk of stroke

Eating at least two servings of oily fish a week is moderately but significantly associated with a reduced risk of stroke, finds a study published on bmj.com today. [More]
FDA accepts Sunovion’s two LATUDA sNDAs for review

FDA accepts Sunovion’s two LATUDA sNDAs for review

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review two supplemental New Drug Applications (sNDAs) for the use of LATUDA as 1) monotherapy and 2) adjunctive therapy to lithium or valproate, both to treat adult patients with depressive episodes associated with bipolar I disorder (bipolar depression). [More]
Stay active to keep a healthy mind in very old age

Stay active to keep a healthy mind in very old age

Poor physical performance, especially a slow walking speed, is significantly associated with dementia in individuals aged over 90 years, show study results. [More]
New anti-thrombotic treatments in AF patients can reduce risk of stroke

New anti-thrombotic treatments in AF patients can reduce risk of stroke

Atrial fibrillation, whose prevalence continues to rise, was described last year as the "new epidemic" in cardiovascular disease, even though AF can be successfully controlled by the detection and management of risk factors, by rhythm control treatments, and by the use of antithrombotic therapies. [More]

Lean principles help improve stroke treatment at Barnes-Jewish Hospital

A process developed to increase efficiency and productivity in Japanese car factories has helped improve stroke treatment at Barnes-Jewish Hospital, report researchers at Washington University School of Medicine in St. Louis. [More]
Smartphone stroke assessment shows promise

Smartphone stroke assessment shows promise

A smartphone application that assists vascular neurologists with the assessment of possible stroke patients shows excellent agreement with the interpretations of other radiologists and independent, blinded adjudicators, say researchers. [More]

Early blood pressure control reduces future CV events in diabetes

Type 2 diabetes patients who fail to properly control their blood pressure within a year of being diagnosed with hypertension face an elevated risk for future major cardiovascular events for up to 3 years subsequently, study results show. [More]

Stroke patients on a downhill memory slope

The large memory declines associated with acute stroke are part of a long-term downward trajectory, show findings from the Health and Retirement Study. [More]